EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dissecting Missing Heritability in Rare Inherited Macular Dystrophies

Deirdre Harford, Marcus Conway, Bridget Moran, Julia Zhu iD, Jacqueline Turner, Adrian Dockery iD, James J O'Byrne, D Ian Flitcroft iD, Tomás Burke, Kirk A J Stephenson iD, G Jane Farrar, David J Keegan

Genes · 20.08.2026 · 17 (8) · 979

DOI: 10.3390/genes17080979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 20.08.2026. Verfasst von Deirdre Harford und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, Eccles Street, D07 R2WY Dublin, Ireland. Hauptthemen laut MEDLINE: Macular Degeneration. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fighting Blindness, Health Research Board, Health Research Charities Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: To describe the genetic resolution rate, molecular findings, and genotype–phenotype correlations of non-ABCA4 and non-BEST1 inherited macular dystrophies (IMDs) within an Irish inherited retinal disease (IRD) registry.

Methods

Retrospective review of individuals with a clinical diagnosis of macular or cone dystrophy. Comprehensive phenotyping (dilated ocular biomicroscopy, multimodal retinal imaging, visual electrophysiology) and genetic testing (panel-based next-generation sequencing, single-gene testing, whole exome/genome sequencing, WES/WGS). Variants were interpreted using ACMG AMP criteria, and genotype-phenotype match was confirmed through multidisciplinary review.

Results

232 patients with macular/cone dystrophies were identified. ABCA4 and BEST1 accounted for most molecular diagnoses (47.4%). Removing ABCA4 and BEST1, 59.0% of IMDs were genetically unresolved, higher than the rate in general IRD cohorts. Deep phenotyping enabled diagnostic reclassification in 13/72 (18.1%), namely achromatopsia, congenital stationary night blindness, and oculocutaneous albinism. Further genetic testing resolved 35/72 (48.6%) of those unresolved on first-line testing, with PRPH2 being most prevalent (n = 12), followed by GUCY2D, CRB1, PROM1, and CRX. Characteristic phenotypic signatures—such as CRB1-associated retinal thickening and retinoschisis or PROM1-associated Stargardt-like changes—supported known genotype–phenotype correlations.

Conclusions

Genetic resolution rates for rare IMDs remain lower than pan-retinal IRD phenotypes. Beyond ABCA4 and BEST1, IMDs exhibit substantial genetic and phenotypic heterogeneity (24 genotypes in this cohort), with low molecular diagnostic rates despite comprehensive sequencing approaches. Detailed multimodal phenotyping (i.e., structural, functional and extra-ocular) is essential to refine diagnosis, guide genetic testing and interpret candidate variants. Genetic testing is challenging when the retinal phenotype is advanced (i.e., atrophy) or lacks pathognomonic features. Meticulous phenotyping (functional, structural and systemic) and broader genomic strategies (e.g., WES/WGS) may further increase diagnostic yield, though gene panel content is constantly improving. Consistently improving molecular diagnostic rates will ensure equitable access to emerging gene-specific therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular DegenerationHumansATP-Binding Cassette TransportersFemaleMalePhenotypeGenetic Association StudiesPeripherinsBestrophinsRetrospective StudiesEye Diseases, HereditaryAdultGenetic TestingMiddle AgedChildMyopiaNight BlindnessGenetic Diseases, X-Linked

Stichwörter der Autor:innen

deep phenotypinginherited eye diseasemacular dystrophymissing heritabilityophthalmic geneticsophthalmology

Substanzen

ATP-Binding Cassette TransportersABCA4 protein, humanPeripherinsBestrophinsPRPH2 protein, humanBEST1 protein, human

Autor:innen und Institutionen

  • Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, Eccles Street, D07 R2WY Dublin, Ireland.
  • Next Generation Sequencing Laboratory, Mater Misericordiae University Hospital, Eccles Street, D07 R2WY Dublin, Ireland.
  • Children's Health Ireland at Temple Street Hospital, D01 XD99 Dublin, Ireland.
  • Smurfit Institute of Genetics, Trinity College Dublin, D02 PN40 Dublin, Ireland.

ORCID-Profile: Julia Zhu, Adrian Dockery, D Ian Flitcroft, Kirk A J Stephenson

Förderung

  • Fighting Blindness
  • Health Research Board
  • Health Research Charities Ireland
  • Science Foundation Ireland
  • The Health Research Board

Zitieren

APA

Harford, D., Conway, M., Moran, B., Zhu, J., Turner, J., Dockery, A., O'Byrne, J. J., Flitcroft, D. I., Burke, T., Stephenson, K. A. J., Farrar, G. J., & Keegan, D. J. (2026). Dissecting Missing Heritability in Rare Inherited Macular Dystrophies. Genes, 17(8), 979. https://doi.org/10.3390/genes17080979

Vancouver

Harford D, Conway M, Moran B, Zhu J, Turner J, Dockery A, et al. Dissecting Missing Heritability in Rare Inherited Macular Dystrophies. Genes. 2026;17(8):979. doi:10.3390/genes17080979

BibTeX
@article{Harford2026,
  author = {Harford, Deirdre and Conway, Marcus and Moran, Bridget and Zhu, Julia and Turner, Jacqueline and Dockery, Adrian and O'Byrne, James J and Flitcroft, D Ian and Burke, Tomás and Stephenson, Kirk A J and Farrar, G Jane and Keegan, David J},
  title = {Dissecting Missing Heritability in Rare Inherited Macular Dystrophies},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {8},
  pages = {979},
  doi = {10.3390/genes17080979}
}
Kostenlos starten →